Log in to save to my catalogue

Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastom...

Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastom...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1839116865

Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells

About this item

Full title

Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells

Publisher

New York: Springer US

Journal title

Molecular neurobiology, 2017-12, Vol.54 (10), p.7610-7619

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Neuroblastoma (NB) is the most common extracranial solid childhood tumor accounting for around 15% of pediatric cancer deaths and most probably originates from a failure in the development of embryonic neural crest cells. Retinoids can inhibit the proliferation and stimulate differentiation of NB cells. In addition, epigenetic events involving chan...

Alternative Titles

Full title

Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1839116865

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1839116865

Other Identifiers

ISSN

0893-7648

E-ISSN

1559-1182

DOI

10.1007/s12035-016-0250-3

How to access this item